How do genes, proteins, and other molecules interact within the cell? How can therapeutic pathways be identified to treat complex diseases? A new BELLA II Testbed, which focuses on bioinformatics, provides an advanced research environment that combines data from various sources with Artificial Intelligence (AI) tools, helping to advance studies in biotechnology and personalized medicine.
The workshop “Connecting Minds, Transforming Realities,” which will serve as a prelude to RedCLARA’s annual meeting TICAL2025, invites researchers, academics, entrepreneurs, students, and professionals to experience a unique hands-on innovation journey. The event will take place on November 10, from 9:00 a.m. to 5:00 p.m., at the Hilton Cariari Hotel in San José. During the day, participants will learn how to turn ideas into real projects, explore successful methodologies from the region, and discover how research and education networks can transform concepts into concrete solutions that benefit society.
“Innovation with Purpose. When the Network Maximizes Its Impact” is the title of the virtual session to be held on September 9 at 15:00 GMT, serving as a prelude to the in-person Open Innovation Workshop, scheduled for November 10 in San José, Costa Rica, within the framework of the TICAL2025 conference.
 |
BELLA II receives funding from the European Union through the Neighbourhood, Development and International Cooperation Instrument (NDICI), under agreement number 438-964 with DG-INTPA, signed in December 2022. The implementation period of BELLA II is 48 months. |
For more information about BELLA II please contact: